What is Agilysys, Inc.'s earnings per share (EPS)?

Agilysys, Inc. (AGYS) reported diluted earnings per share of $1.37 for fiscal year 2026. This represents a 67.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Agilysys, Inc. (AGYS) Financials

AGYS

Trailing 12 months to June 30, 2026

Revenue $330.3M +14.4% YoY

Net Income $42.9M +206.2% YoY

EPS (Diluted) $1.52 +204.0% YoY

Free Cash Flow $80.4M +70.7% YoY

Market Cap $2.8B as of Oct 5, 2026

Price / Sales 8.5x on $330.3M revenue, trailing 12 months to June 30, 2026

Price / Earnings 65.4x on $42.9M net income, trailing 12 months to June 30, 2026

Price / Book 8.3x on $338.3M equity, Q1 FY2027

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 30, 2026 Reported Jul 27, 2026 Currency USD FYE March

Newest figures come from the 10-Q for Q1 FY2027, filed Jul 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AGYS SEC filings page.

Agilysys, Inc. (AGYS) reported $330.3M in revenue over the twelve months to Jun 30, 2026, up 14.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AGYS FY2026 2026-10-03

Agilysys is becoming a higher-margin, debt-free software business with cash generation that largely funds its growth.

Between FY2024 and FY2026, operating margin rose from 6.6% to 13.5%. Stable gross margin alongside that expansion points to operating-cost absorption, not simply a change in what the company sells.

FY2026 operating cash flow was $70.0M versus net income of $38.8M, showing earnings converted into cash without relying on a large accounting gain. Free cash flow was $68.1M against $1.8M of capital expenditures, so reported reinvestment remains light relative to cash generation.

Long-term debt fell from $24.0M to zero, reducing financing dependence. The current ratio improved from 1.1x to 1.5x, indicating more short-term asset coverage than the prior year.

Financial Health Signals

Financial Health Score 72/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Agilysys, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Agilysys, Inc. has an operating margin of 13.5%, meaning the company retains $13 of operating profit per $100 of revenue. This strong profitability earns a score of 65/100, reflecting efficient cost management and pricing power. This is up from 8.2% the prior year.

Growth

Agilysys, Inc.'s revenue surged 15.9% year-over-year to $319.3M, reflecting rapid business expansion. This strong growth earns a score of 77/100.

Leverage

Agilysys, Inc. carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Agilysys, Inc.'s current ratio of 1.47 indicates adequate short-term liquidity, earning a score of 40/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Agilysys, Inc. converts 21.3% of revenue into free cash flow ($68.1M). This strong cash generation earns a score of 86/100.

Returns

Agilysys, Inc. earns a strong 11.9% return on equity (ROE), meaning it generates $12 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 65/100. This is up from 8.7% the prior year.

Altman Z-Score Safe

12.57

Agilysys, Inc. scores 12.57, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.8B) relative to total liabilities ($154.7M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

8/9

Agilysys, Inc. passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.80x

For every $1 of reported earnings, Agilysys, Inc. generates $1.80 in operating cash flow ($70.0M OCF vs $38.8M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

87.25x

Agilysys, Inc. earns $87.25 in operating income for every $1 of interest expense ($43.0M vs $493K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$87.7M

YoY+14.3%

QoQ+5.7%

5Y CAGR+17.8%

10Y CAGR+10.0%

Agilysys, Inc. generated $87.7M in revenue in Q1 2027. This represents an increase of 14.3% from the same quarter a year earlier. Against the prior quarter it is up 5.7%.

EBITDA

$12.0M

YoY+73.2%

QoQ-19.9%

5Y CAGR+31.3%

Agilysys, Inc.'s EBITDA was $12.0M in Q1 2027, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 73.2% from the same quarter a year earlier. Against the prior quarter it is down 19.9%.

Net Income

$9.0M

YoY+83.9%

QoQ-26.9%

5Y CAGR+35.5%

Agilysys, Inc. reported $9.0M in net income in Q1 2027. This represents an increase of 83.9% from the same quarter a year earlier. Against the prior quarter it is down 26.9%.

EPS (Diluted)

$0.32

YoY+88.2%

QoQ-27.3%

5Y CAGR+39.8%

Agilysys, Inc. earned $0.32 per diluted share (EPS) in Q1 2027. This represents an increase of 88.2% from the same quarter a year earlier. Against the prior quarter it is down 27.3%.

Cash & Balance Sheet

Free Cash Flow

$7.3M

YoY+246.9%

QoQ-79.3%

5Y CAGR-1.1%

Agilysys, Inc. generated $7.3M in free cash flow in Q1 2027, representing cash available after capex. This represents an increase of 246.9% from the same quarter a year earlier. Against the prior quarter it is down 79.3%.

Cash & Debt

$123.7M

YoY+122.6%

QoQ+5.8%

5Y CAGR+3.5%

10Y CAGR+8.4%

Agilysys, Inc. held $123.7M in cash as of Q1 2027; long-term debt is not reported for that period.

Shares Outstanding

28M

YoY+0.6%

QoQ+0.1%

5Y CAGR+2.8%

10Y CAGR+2.1%

Agilysys, Inc. had 28M shares outstanding in Q1 2027. This represents an increase of 0.6% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Dividends Per Share

Not reported for Q1 2027.

Margins & Returns

Gross Margin

63.5%

YoY+1.8pp

QoQ-0.9pp

5Y change-0.7pp

10Y change+14.3pp

Agilysys, Inc.'s gross margin was 63.5% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.9 percentage points.

Operating Margin

11.1%

YoY+5.2pp

QoQ-4.1pp

5Y change+5.8pp

Agilysys, Inc.'s operating margin was 11.1% in Q1 2027, reflecting core business profitability. This is up 5.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.1 percentage points.

Net Margin

10.3%

YoY+3.9pp

QoQ-4.6pp

5Y change+5.2pp

10Y change+19.0pp

Agilysys, Inc.'s net profit margin was 10.3% in Q1 2027, showing the share of revenue converted to profit. This is up 3.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.6 percentage points.

Return on Equity

2.7%

YoY+0.9pp

QoQ-1.1pp

5Y change+0.3pp

10Y change+5.1pp

Agilysys, Inc.'s ROE was 2.7% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is up 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Capital Allocation

R&D Spending

$20.2M

YoY+16.0%

QoQ+9.2%

5Y CAGR+12.0%

Agilysys, Inc. invested $20.2M in research and development in Q1 2027. This represents an increase of 16.0% from the same quarter a year earlier. Against the prior quarter it is up 9.2%.

Capital Expenditures

$520K

YoY-17.9%

QoQ+22.6%

5Y CAGR+13.7%

10Y CAGR-4.4%

Agilysys, Inc. invested $520K in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 17.9% from the same quarter a year earlier. Against the prior quarter it is up 22.6%.

Share Buybacks

Not reported for Q1 2027.

AGYS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AGYS quarterly income statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Revenue	$330.3M	$319.3M+15.9%	$275.6M+16.1%	$237.5M+19.9%	$198.1M+21.8%	$162.6M+18.6%	$137.2M-14.7%	$160.8M+14.1%	$140.8M+10.6%	$127.4M-0.2%	$127.7M+6.1%	$120.4M+16.3%	$103.5M+2.2%	$101.3M+7.7%	$94.0M+14.6%	$82.1M
Cost of Revenue	$122.0M	$119.4M+15.2%	$103.6M+11.2%	$93.2M+20.7%	$77.2M+26.4%	$61.1M+27.8%	$47.8M-40.1%	$79.8M+19.2%	$67.0M+6.4%	$62.9M-1.5%	$63.9M+22.3%	$52.3M+20.3%	$43.4M+16.7%	$37.2M+2.3%	$36.4M+12.2%	$32.4M
Gross Profit	$208.3M	$199.9M+16.2%	$172.0M+19.2%	$144.3M+19.4%	$120.8M+19.0%	$101.5M+13.6%	$89.4M+10.4%	$81.0M+9.6%	$73.9M+14.7%	$64.4M+1.0%	$63.8M-6.3%	$68.1M+13.4%	$60.1M-6.2%	$64.0M+11.1%	$57.6M+16.1%	$49.6M
R&D Expenses	$75.5M	$72.7M+16.6%	$62.4M+10.0%	$56.7M+12.9%	$50.3M+8.5%	$46.3M-16.3%	$55.3M+33.5%	$41.5M+9.6%	$37.8M+35.4%	$27.9M-3.8%	$29.0M+8.8%	$26.7M+5.4%	$25.3M+0.4%	$25.2M+5.5%	$23.9M+9.4%	$21.8M
SG&A Expenses	$42.6M	$42.2M+3.4%	$40.8M-68.2%	$128.5M+19.0%	$107.9M+13.4%	$95.2M-13.7%	$110.3M-4.1%	$115.0M+32.3%	$87.0M+13.7%	$76.5M+284.9%	$19.9M-8.9%	$21.8M+0.7%	$21.7M+4.4%	$20.8M-1.1%	$21.0M-23.1%	$27.3M
Operating Income	$48.2M	$43.0M+90.4%	$22.6M+43.4%	$15.8M+22.4%	$12.9M+103.8%	$6.3M+130.2%	-$21.0M+38.5%	-$34.1M-160.4%	-$13.1M-8.3%	-$12.1M-5.9%	-$11.4M-164.5%	-$4.3M+65.4%	-$12.5M-101.5%	-$6.2M+33.5%	-$9.3M+79.7%	-$45.8M
EBITDA	N/A	$52.6M+74.6%	$30.1M+43.4%	$21.0M+28.2%	$16.4M+60.7%	$10.2M+163.2%	-$16.1M+44.2%	-$28.9M-261.1%	-$8.0M-5.8%	-$7.6M+0.5%	-$7.6M-773.4%	-$871K+87.2%	-$6.8M-394.8%	$2.3M+159.2%	-$3.9M+89.9%	-$38.3M
Interest Expense	$346K	$493K-67.8%	$1.5M	$0	$0-100.0%	$12K-40.0%	$20K+122.2%	$9K-10.0%	$10K0.0%	$10K-33.3%	$15K-48.3%	$29K-39.6%	$48K-73.9%	$184K-30.8%	$266K-71.8%	$943K
Income Tax	$11.5M	$9.6M+299.0%	$2.4M+103.7%	-$65.5M-5642.4%	$1.2M+3481.8%	$33K+115.9%	-$208K-203.5%	$201K-9.0%	$221K+106.8%	-$3.3M-1477.5%	$236K+3833.3%	$6K+100.6%	-$1.1M+57.7%	-$2.5M+20.1%	-$3.1M+66.0%	-$9.2M
Net Income	$42.9M	$38.8M+67.0%	$23.2M-73.1%	$86.2M+491.1%	$14.6M+125.1%	$6.5M+130.8%	-$21.0M+38.4%	-$34.1M-158.8%	-$13.2M-57.7%	-$8.3M+28.8%	-$11.7M-211.3%	-$3.8M+67.3%	-$11.5M-167.2%	$17.1M+1417.2%	-$1.3M+94.3%	-$22.8M
EPS (Basic)	N/A	$1.39+65.5%	$0.84-74.6%	$3.31+536.5%	$0.52+173.7%	$0.19+118.8%	-$1.01+31.3%	-$1.47	N/A	N/A	N/A	-$0.17+66.7%	-$0.51-166.2%	$0.77+1383.3%	-$0.06	N/A
EPS (Diluted)	$1.52	$1.37+67.1%	$0.82-74.1%	$3.17+546.9%	$0.49+172.2%	$0.18	-$1.01+31.3%	-$1.47	N/A	N/A	N/A	N/A	N/A	$0.77+1383.3%	-$0.06	N/A
Diluted Shares (Avg)	N/A	28M+0.5%	28M+5.3%	27M+3.5%	26M+1.8%	25M	23M+1.0%	23M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Revenue	$87.7M+14.3%	$82.9M+11.7%	$80.4M+15.6%	$79.3M+16.1%	$76.7M+20.7%	$74.3M+19.4%	$69.6M+14.9%	$68.3M+16.5%
Cost of Revenue	$32.0M+9.0%	$29.5M+1.1%	$30.1M+17.3%	$30.3M+21.0%	$29.4M+24.3%	$29.2M+22.0%	$25.7M+13.0%	$25.1M+6.6%
Gross Profit	$55.7M+17.7%	$53.4M+18.6%	$50.2M+14.6%	$49.0M+13.3%	$47.3M+18.6%	$45.1M+17.7%	$43.9M+15.9%	$43.2M+23.1%
R&D Expenses	$20.2M+16.0%	$18.5M+12.0%	$18.9M+26.4%	$17.8M+10.2%	$17.5M+18.6%	$16.5M+15.8%	$15.0M+2.9%	$16.2M+10.9%
SG&A Expenses	$11.1M+3.3%	$10.5M+115.2%	$10.8M-70.3%	$10.2M-74.0%	$10.8M-68.5%	-$68.8M-297.8%	$36.4M+21.2%	$39.1M+24.0%
Operating Income	$9.7M+115.4%	$12.6M+137.7%	$11.7M+58.3%	$14.1M+242.9%	$4.5M-21.3%	$5.3M+52.4%	$7.4M-4.4%	$4.1M+15.8%
EBITDA	$12.0M+73.2%	$15.0M+104.3%	$14.2M+41.3%	$16.5M+178.3%	$6.9M+1.3%	$7.3M+59.9%	$10.0M+11.3%	$5.9M+16.2%
Interest Expense	$70K-67.7%	$190K-54.1%	$30K-95.4%	$56K-87.8%	$217K	$414K	$657K	$458K
Income Tax	$1.8M+4536.6%	$2.7M+84.3%	$3.0M-23.7%	$4.0M+5.8%	-$41K+99.4%	$1.4M-23.1%	$3.9M+105.8%	$3.8M+1182.0%
Net Income	$9.0M+83.9%	$12.3M+213.2%	$9.9M+158.4%	$11.7M+758.5%	$4.9M-65.3%	$3.9M+32.6%	$3.8M-95.0%	$1.4M-70.0%
EPS (Basic)	$0.32+77.8%	$0.44+214.3%	$0.35+150.0%	$0.42+740.0%	$0.18-65.4%	$0.14+133.3%	$0.14-95.3%	$0.05-68.8%
EPS (Diluted)	$0.32+88.2%	$0.44+214.3%	$0.35+150.0%	$0.41+720.0%	$0.17-66.0%	$0.14	$0.14-95.1%	$0.05-68.8%
Diluted Shares (Avg)	28M+0.5%	N/A	28M+0.4%	28M+0.5%	28M+0.6%	N/A	28M+4.9%	28M+8.2%

AGYS Balance Sheet

AGYS quarterly balance sheet

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Total Assets	$481.5M+10.9%	$434.4M+24.0%	$350.4M+44.2%	$243.0M+13.5%	$214.2M+12.8%	$189.9M+22.8%	$154.6M-5.5%	$163.6M+4.1%	$157.2M-6.0%	$167.3M-9.6%	$185.2M+2.0%	$181.5M-4.9%	$190.9M-3.3%	$197.5M-3.3%	$204.1M
Current Assets	$184.1M+49.1%	$123.5M-34.6%	$188.9M+22.2%	$154.7M+13.6%	$136.2M+2.2%	$133.3M+42.7%	$93.4M+18.2%	$79.0M+23.6%	$63.9M-13.1%	$73.5M-23.0%	$95.5M-9.1%	$105.0M-19.1%	$129.9M-11.2%	$146.3M-5.2%	$154.3M
Cash & Equivalents	$116.9M+60.0%	$73.0M-49.6%	$144.9M+28.4%	$112.8M+16.4%	$97.0M-2.2%	$99.2M+112.6%	$46.7M+14.4%	$40.8M+2.1%	$39.9M-18.9%	$49.3M-18.7%	$60.6M-19.3%	$75.1M-24.6%	$99.6M+20.8%	$82.4M-13.7%	$95.5M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$7.5M+45.5%	$5.2M+12.8%	$4.6M-53.1%	$9.8M+40.8%	$6.9M+489.6%	$1.2M-69.7%	$3.9M+90.2%	$2.0M+2.3%	$2.0M-9.6%	$2.2M-17.9%	$2.7M+320.0%	$641K+33.3%	$481K-40.5%	$809K-94.9%	$15.7M
Accounts Receivable	$43.1M+36.6%	$31.5M+7.1%	$29.4M+31.6%	$22.4M-11.1%	$25.2M-2.2%	$25.7M-28.3%	$35.9M+32.8%	$27.0M+64.7%	$16.4M+5.1%	$15.6M-29.2%	$22.0M-13.6%	$25.5M+7.9%	$23.6M+51.5%	$15.6M-52.1%	$32.5M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$133.9M+2.5%	$130.6M+298.4%	$32.8M+0.5%	$32.6M-0.4%	$32.8M+67.0%	$19.6M0.0%	$19.6M0.0%	$19.6M0.0%	$19.6M+0.1%	$19.6M-0.1%	$19.6M0.0%	$19.6M+14.4%	$17.2M+21.4%	$14.1M-7.0%	$15.2M
Total Liabilities	$154.7M-8.2%	$168.5M+47.9%	$114.0M-14.8%	$133.7M+14.5%	$116.8M+6.2%	$110.0M+32.8%	$82.8M+31.5%	$63.0M+29.1%	$48.8M-9.1%	$53.6M-13.0%	$61.7M+7.6%	$57.3M-1.2%	$58.0M-30.6%	$83.6M-6.8%	$89.7M
Current Liabilities	$125.1M+12.7%	$111.0M+24.2%	$89.4M+13.8%	$78.5M+9.9%	$71.5M+16.9%	$61.2M-11.9%	$69.4M+20.1%	$57.8M+29.7%	$44.6M-3.8%	$46.3M-14.3%	$54.1M+6.9%	$50.6M+5.1%	$48.1M-35.1%	$74.2M-4.9%	$78.0M
Non-Current Liabilities	$29.6M-48.4%	$57.5M+133.7%	$24.6M-55.5%	$55.2M+21.7%	$45.4M-7.1%	$48.8M+265.0%	$13.4M+159.6%	$5.2M+22.9%	$4.2M-42.5%	$7.3M-3.8%	$7.6M+12.7%	$6.7M-31.9%	$9.9M+4.3%	$9.5M-19.0%	$11.7M
Long-Term Debt	$0-100.0%	$24.0M	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$326.8M+22.9%	$265.9M+12.4%	$236.5M+116.3%	$109.3M+12.3%	$97.3M+21.9%	$79.9M+11.3%	$71.8M-28.7%	$100.6M-7.2%	$108.4M-4.6%	$113.7M-7.9%	$123.5M-0.6%	$124.2M-6.5%	$132.9M+16.7%	$113.9M-0.5%	$114.4M
Retained Earnings	$199.8M+24.1%	$161.0M+16.9%	$137.8M+161.1%	$52.8M+31.9%	$40.0M+13.1%	$35.4M-40.0%	$59.0M-36.6%	$93.1M-10.2%	$103.6M-8.1%	$112.7M-9.4%	$124.4M-2.9%	$128.2M-8.2%	$139.7M+13.9%	$122.6M-1.0%	$123.9M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Total Assets	$472.8M+11.0%	$481.5M+10.9%	$475.2M+7.1%	$425.6M-3.7%	$426.0M+19.8%	$434.4M+24.0%	$443.9M+28.0%	$442.0M+73.2%
Current Assets	$182.4M+68.1%	$184.1M+49.1%	$169.8M+29.4%	$118.0M+8.5%	$108.5M-41.9%	$123.5M-34.6%	$131.2M-28.6%	$108.7M-29.1%
Cash & Equivalents	$123.7M+122.6%	$116.9M+60.0%	$81.5M+34.1%	$59.3M+8.1%	$55.6M-61.4%	$73.0M-49.6%	$60.8M-47.7%	$54.9M-48.9%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$7.9M+19.7%	$7.5M+45.5%	$7.8M+22.5%	$7.7M+19.7%	$6.6M+25.0%	$5.2M+12.8%	$6.4M-6.1%	$6.4M-13.9%
Accounts Receivable	$36.6M+4.5%	$43.1M+36.6%	$63.7M+29.3%	$36.8M+16.4%	$35.1M+28.4%	$31.5M+7.1%	$49.3M-0.2%	$31.6M+13.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$131.6M-3.3%	$133.9M+2.5%	$135.8M+5.7%	$134.1M-1.0%	$136.1M+316.7%	$130.6M+298.4%	$128.5M+288.6%	$135.4M+313.5%
Total Liabilities	$134.5M-5.8%	$154.7M-8.2%	$162.1M-13.4%	$128.8M-29.1%	$142.8M+40.7%	$168.5M+47.9%	$187.1M+60.7%	$181.7M+31.1%
Current Liabilities	$104.8M+7.4%	$125.1M+12.7%	$129.9M+13.0%	$96.7M+0.9%	$97.6M+26.0%	$111.0M+24.2%	$115.0M+26.0%	$95.9M+31.9%
Non-Current Liabilities	$29.7M-34.3%	$29.6M-48.4%	$32.2M-55.4%	$32.1M-62.6%	$45.3M+87.7%	$57.5M+133.7%	$72.1M+186.4%	$85.9M+30.3%
Long-Term Debt	N/A	$0-100.0%	$0-100.0%	$0-100.0%	$12.0M	$24.0M	$38.0M	$50.0M
Total Equity	$338.3M+19.5%	$326.8M+22.9%	$313.1M+21.9%	$296.7M+14.0%	$283.2M+11.4%	$265.9M+12.4%	$256.8M+11.5%	$260.3M+123.2%
Retained Earnings	$208.8M+25.9%	$199.8M+24.1%	$187.5M+19.4%	$177.6M+15.9%	$165.9M+9.2%	$161.0M+16.9%	$157.1M+16.5%	$153.2M+164.5%

AGYS Cash Flow Statement

AGYS quarterly cash flow statement

Metric	TTM	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Operating Cash Flow	$82.2M	$70.0M+27.0%	$55.1M+14.4%	$48.2M+39.8%	$34.5M+21.0%	$28.5M+0.2%	$28.4M+168.6%	$10.6M+46.0%	$7.2M+5.3%	$6.9M+100.2%	$3.4M-52.4%	$7.2M+430.2%	-$2.2M-3094.5%	$73K+100.7%	-$10.7M+50.7%	-$21.7M
Depreciation & Amortization	N/A	$9.6M+27.2%	$7.5M+43.2%	$5.3M+49.8%	$3.5M-9.4%	$3.9M-19.4%	$4.8M-6.2%	$5.1M+1.3%	$5.1M+12.4%	$4.5M+18.7%	$3.8M+10.4%	$3.4M-39.5%	$5.7M-33.0%	$8.5M+56.6%	$5.4M-28.2%	$7.5M
Stock-Based Compensation	N/A	$21.8M+22.7%	$17.8M+26.0%	$14.1M+8.9%	$13.0M-10.9%	$14.5M-63.7%	$40.1M+670.3%	$5.2M+18.9%	$4.4M-6.7%	$4.7M+93.2%	$2.4M-28.7%	$3.4M+8.4%	$3.1M+48.2%	$2.1M+29.4%	$1.6M-31.7%	$2.4M
Capital Expenditures	$1.7M	$1.8M-33.6%	$2.8M-65.8%	$8.1M+12.3%	$7.2M+504.7%	$1.2M-13.8%	$1.4M-59.4%	$3.4M+3.1%	$3.3M-46.0%	$6.1M+47.7%	$4.2M-29.5%	$5.9M+26.9%	$4.7M+15.6%	$4.0M+58.9%	$2.5M+13.5%	$2.2M
Free Cash Flow	$80.4M	$68.1M+30.2%	$52.3M+30.7%	$40.1M+47.1%	$27.2M-0.2%	$27.3M+1.0%	$27.0M+277.6%	$7.2M+82.4%	$3.9M+434.5%	$734K+201.2%	-$725K-155.0%	$1.3M+119.3%	-$6.8M-73.1%	-$4.0M+70.2%	-$13.2M+44.7%	-$23.9M
Investing Cash Flow	-$1.7M	-$1.8M+98.8%	-$148.6M-1854.3%	-$7.6M-10.7%	-$6.9M+73.2%	-$25.7M-1746.1%	-$1.4M+59.6%	-$3.4M+37.7%	-$5.5M+63.3%	-$15.1M-8.8%	-$13.9M+34.0%	-$21.0M+2.9%	-$21.6M-223.1%	$17.6M+675.5%	-$3.1M-105.1%	$60.3M
Financing Cash Flow	-$12.0M	-$24.5M-211.6%	$21.9M+356.2%	-$8.6M+22.9%	-$11.1M-126.4%	-$4.9M-119.4%	$25.3M+2368.5%	-$1.1M-45.5%	-$767K+40.8%	-$1.3M	N/A	-$577K-43.9%	-$401K+58.4%	-$963K-9.8%	-$877K+94.3%	-$15.4M
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0	$0-100.0%	$13.2M

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Operating Cash Flow	$7.8M+280.2%	$35.8M+32.0%	$23.3M+14.8%	$15.2M+130.8%	-$4.3M-495.8%	$27.2M-8.9%	$20.3M+57.2%	$6.6M+21.0%
Depreciation & Amortization	$2.3M-6.2%	$2.4M+16.7%	$2.4M-6.9%	$2.4M+31.7%	$2.4M+120.5%	$2.0M+83.9%	$2.6M+108.2%	$1.8M+16.9%
Stock-Based Compensation	$6.0M+19.1%	N/A	$5.8M+36.8%	$5.0M+24.7%	$5.0M+13.5%	N/A	$4.2M+15.9%	$4.0M+49.4%
Capital Expenditures	$520K-17.9%	$424K-39.5%	$574K+2.1%	$217K-66.7%	$633K-27.2%	$701K+49.5%	$562K-66.1%	$651K-77.8%
Free Cash Flow	$7.3M+246.9%	$35.4M+33.9%	$22.7M+15.2%	$15.0M+152.5%	-$5.0M-2274.2%	$26.5M-9.8%	$19.7M+75.3%	$5.9M+136.5%
Investing Cash Flow	-$520K+17.9%	-$424K+72.0%	-$574K+2.5%	-$217K+99.9%	-$633K+27.2%	-$1.5M-2706.9%	-$589K+64.4%	-$145.6M-4857.3%
Financing Cash Flow	-$419K+96.8%	$113K+100.8%	-$615K+95.4%	-$11.0M-122.3%	-$12.9M-1297.2%	-$13.3M-1049.5%	-$13.4M-414.3%	$49.6M+2478.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

AGYS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AGYS quarterly financial ratios

Metric	FY2610-K	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K
Gross Margin	62.6%+0.2pp	62.4%+1.6pp	60.8%-0.2pp	61.0%-1.4pp	62.4%-2.7pp	65.1%+14.8pp	50.4%-2.1pp	52.5%+1.9pp	50.6%+0.6pp	50.0%-6.6pp	56.6%-1.5pp	58.0%-5.2pp	63.2%+1.9pp	61.3%+0.8pp	60.5%
Operating Margin	13.5%+5.3pp	8.2%+1.6pp	6.6%+0.1pp	6.5%+2.6pp	3.9%+19.2pp	-15.3%+5.9pp	-21.2%-11.9pp	-9.3%+0.2pp	-9.5%-0.5pp	-8.9%-5.4pp	-3.6%+8.5pp	-12.0%-5.9pp	-6.1%+3.8pp	-9.9%+46.0pp	-55.9%
Net Margin	12.2%+3.7pp	8.4%-27.9pp	36.3%+28.9pp	7.4%+3.4pp	4.0%+19.3pp	-15.3%+5.9pp	-21.2%-11.8pp	-9.3%-2.8pp	-6.6%+2.6pp	-9.2%-6.1pp	-3.1%+8.0pp	-11.1%-28.0pp	16.9%+18.3pp	-1.4%+26.4pp	-27.8%
Return on Equity	11.9%+3.1pp	8.7%-27.7pp	36.4%+23.1pp	13.3%+6.7pp	6.7%+32.9pp	-26.3%+21.2pp	-47.5%-34.4pp	-13.1%-5.4pp	-7.7%+2.6pp	-10.3%-7.3pp	-3.0%+6.2pp	-9.3%-22.1pp	12.9%+14.0pp	-1.1%+18.8pp	-19.9%
Return on Assets	8.1%+2.7pp	5.3%-19.3pp	24.6%+18.6pp	6.0%+3.0pp	3.0%+14.1pp	-11.1%+11.0pp	-22.0%-14.0pp	-8.1%-2.7pp	-5.3%+1.7pp	-7.0%-5.0pp	-2.0%+4.3pp	-6.3%-15.3pp	9.0%+9.6pp	-0.7%+10.5pp	-11.2%
Current Ratio	1.47+0.4x	1.11-1.0x	2.11+0.1x	1.97+0.1x	1.91-0.3x	2.18+0.8x	1.350.0x	1.37-0.1x	1.43-0.2x	1.59-0.2x	1.77-0.3x	2.08-0.6x	2.70+0.7x	1.970.0x	1.98
Debt-to-Equity	0.00-0.1x	0.09+0.1x	0.00-1.2x	1.220.0x	1.20-0.2x	1.38+0.2x	1.15+0.5x	0.63+0.2x	0.450.0x	0.470.0x	0.500.0x	0.460.0x	0.44-0.3x	0.730.0x	0.78
Asset Turnover	0.660.0x	0.630.0x	0.68-0.1x	0.81+0.1x	0.760.0x	0.72-0.3x	1.04+0.2x	0.86+0.1x	0.810.0x	0.76+0.1x	0.65+0.1x	0.570.0x	0.53+0.1x	0.48+0.1x	0.40
FCF Margin	21.3%+2.3pp	19.0%+2.1pp	16.9%+3.1pp	13.8%-3.0pp	16.8%-2.9pp	19.7%+15.3pp	4.5%+1.7pp	2.8%+2.2pp	0.6%+1.1pp	-0.6%-1.7pp	1.1%+7.7pp	-6.6%-2.7pp	-3.9%+10.2pp	-14.1%+15.1pp	-29.2%

Metric	Q1'2710-Q	Q4'2610-Q	Q3'2610-Q	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-Q	Q2'2510-Q
Gross Margin	63.5%+1.8pp	64.4%+3.7pp	62.5%-0.5pp	61.8%-1.5pp	61.7%-1.1pp	60.7%-0.9pp	63.0%+0.6pp	63.3%+3.4pp
Operating Margin	11.1%+5.2pp	15.2%+8.1pp	14.6%+3.9pp	17.8%+11.8pp	5.9%-3.1pp	7.1%+1.5pp	10.7%-2.2pp	6.0%0.0pp
Net Margin	10.3%+3.9pp	14.8%+9.5pp	12.3%+6.8pp	14.8%+12.8pp	6.4%-15.8pp	5.3%+0.5pp	5.5%	2.0%-5.8pp
Return on Equity	2.7%+0.9pp	3.8%+2.3pp	3.2%+1.7pp	4.0%+3.4pp	1.7%-3.8pp	1.5%+0.2pp	1.5%-32.0pp	0.5%-3.4pp
Return on Assets	1.9%+0.8pp	2.5%+1.7pp	2.1%+1.2pp	2.8%+2.4pp	1.1%-2.8pp	0.9%+0.1pp	0.9%-21.4pp	0.3%-1.5pp
Current Ratio	1.74+0.6x	1.47+0.4x	1.31+0.2x	1.22+0.1x	1.11-1.3x	1.11-1.0x	1.14-0.9x	1.13-1.0x
Debt-to-Equity	0.40+0.4x	0.00-0.1x	0.00-0.1x	0.00-0.2x	0.04-0.4x	0.09+0.1x	0.15-0.4x	0.19-1.0x
Asset Turnover	0.190.0x	0.170.0x	0.170.0x	0.190.0x	0.180.0x	0.170.0x	0.160.0x	0.15-0.1x
FCF Margin	8.3%+14.8pp	42.7%+7.1pp	28.3%-0.1pp	18.9%+10.2pp	-6.5%-6.9pp	35.6%-11.5pp	28.4%+9.8pp	8.7%+4.4pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Agilysys, Inc. AGYS	FY2026	$319.3M	$38.8M	12.2%	$2.8B	72/100
Asana, Inc. ASAN	FY2026	$790.8M	-$189.0M	-23.9%	$2.0B	56/100
Dave Inc. DAVE	FY2025	$554.2M	$196.0M	35.4%	$4.4B	61/100
NCR Atleos Corporation NATL	FY2025	$4.4B	$162.0M	3.7%	$3.4B	44/100
RINGCENTRAL, INC. RNG	FY2025	$2.5B	$43.4M	1.7%	$6.5B	48/100
Alarm.com Holdings, Inc. ALRM	FY2025	$1.0B	$131.6M	13.0%	$2.7B	61/100

Where Agilysys, Inc. Ranks

Frequently Asked Questions

What is Agilysys, Inc.'s annual revenue?

Agilysys, Inc. (AGYS) reported $319.3M in total revenue for fiscal year 2026. This represents a 15.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Agilysys, Inc.'s revenue growing?

Agilysys, Inc. (AGYS) revenue grew by 15.9% year-over-year, from $275.6M to $319.3M in fiscal year 2026.

Is Agilysys, Inc. profitable?

Yes, Agilysys, Inc. (AGYS) reported a net income of $38.8M in fiscal year 2026, with a net profit margin of 12.2%.

What is Agilysys, Inc.'s EBITDA?

Agilysys, Inc. (AGYS) had EBITDA of $52.6M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Agilysys, Inc. have?

As of fiscal year 2026, Agilysys, Inc. (AGYS) had $116.9M in cash and equivalents against $0 in long-term debt.

What is Agilysys, Inc.'s gross margin?

Agilysys, Inc. (AGYS) had a gross margin of 62.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is Agilysys, Inc.'s operating margin?

Agilysys, Inc. (AGYS) had an operating margin of 13.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is Agilysys, Inc.'s net profit margin?

Agilysys, Inc. (AGYS) had a net profit margin of 12.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

What is Agilysys, Inc.'s return on equity (ROE)?

Agilysys, Inc. (AGYS) has a return on equity of 11.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is Agilysys, Inc.'s free cash flow?

Agilysys, Inc. (AGYS) generated $68.1M in free cash flow during fiscal year 2026. This represents a 30.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Agilysys, Inc.'s operating cash flow?

Agilysys, Inc. (AGYS) generated $70.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are Agilysys, Inc.'s total assets?

Agilysys, Inc. (AGYS) had $481.5M in total assets as of fiscal year 2026, including both current and long-term assets.

What are Agilysys, Inc.'s capital expenditures?

Agilysys, Inc. (AGYS) invested $1.8M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does Agilysys, Inc. spend on research and development?

Agilysys, Inc. (AGYS) invested $72.7M in research and development during fiscal year 2026.

How many shares does Agilysys, Inc. have outstanding?

Agilysys, Inc. (AGYS) had 28M shares outstanding as of fiscal year 2026.

What is Agilysys, Inc.'s current ratio?

Agilysys, Inc. (AGYS) had a current ratio of 1.47 as of fiscal year 2026, which is considered adequate.

What is Agilysys, Inc.'s debt-to-equity ratio?

Agilysys, Inc. (AGYS) had a debt-to-equity ratio of 0.00 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Agilysys, Inc.'s return on assets (ROA)?

Agilysys, Inc. (AGYS) had a return on assets of 8.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is Agilysys, Inc.'s P/E ratio?

Agilysys, Inc. (AGYS) trades at 65.4x earnings, its market capitalization divided by net income of $42.9M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.8B as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Agilysys, Inc.'s price-to-sales ratio?

Agilysys, Inc. (AGYS) trades at 8.5x sales, its market capitalization divided by revenue of $330.3M revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.8B as of Oct 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Agilysys, Inc.'s Altman Z-Score?

Agilysys, Inc. (AGYS) has an Altman Z-Score of 12.57, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Agilysys, Inc.'s Piotroski F-Score?

Agilysys, Inc. (AGYS) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Agilysys, Inc.'s earnings high quality?

Agilysys, Inc. (AGYS) has an earnings quality ratio of 1.80x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Agilysys, Inc. cover its interest payments?

Agilysys, Inc. (AGYS) has an interest coverage ratio of 87.25x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Agilysys, Inc.?

Agilysys, Inc. (AGYS) scores 72 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.